The multiple functions of collagen XVIII in development and disease

Matrix Biology

Volumn 30, Issue 2, 2011, Pages 83-92

  Seppinen, Lotta ^a   Pihlajaniemi, Taina ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Angiogenesis; Basement membrane; Collagen XVIII; Endostatin

Indexed keywords

COLLAGEN TYPE 18; ENDOSTATIN; HEPARAN SULFATE; WNT PROTEIN;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; BASEMENT MEMBRANE; CAENORHABDITIS ELEGANS; CHICK; EYE DEVELOPMENT; EYE DISEASE; GENE MUTATION; GENETIC DISORDER; HUMAN; KNOBLOCH SYNDROME; MYOPIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RETINA DETACHMENT; REVIEW; TUMOR GROWTH; VITREORETINAL DEGENERATION; XENOPUS LAEVIS; ZEBRA FISH;

ANIMALS; COLLAGEN TYPE XVIII; DISEASE; ENDOSTATINS; GROWTH AND DEVELOPMENT; HUMANS;

CAENORHABDITIS ELEGANS; DANIO RERIO; MUS; XENOPUS LAEVIS;

EID: 79952104610     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2010.11.001     Document Type: Review

References (154)

1. Abdollahi A., Hahnfeldt P., Maercker C., Grone H.J., Debus J., Ansorge W., Folkman J., Hlatky L., Huber P.E. Endostatin's antiangiogenic signaling network. Mol. Cell 2004, 13:649-663.
2. Ackley B.D., Crew J.R., Elamaa H., Pihlajaniemi T., Kuo C.J., Kramer J.M. The NC1/endostatin domain of Caenorhabditis elegans type XVIII collagen affects cell migration and axon guidance. J. Cell Biol. 2001, 152:1219-1232.
3. Ackley B.D., Kang S.H., Crew J.R., Suh C., Jin Y., Kramer J.M. The basement membrane components nidogen and type XVIII collagen regulate organization of neuromuscular junctions in Caenorhabditis elegans. J. Neurosci. 2003, 23:3577-3587.
4. Aricescu A.R., McKinnell I.W., Halfter W., Stoker A.W. Heparan sulfate proteoglycans are ligands for receptor protein tyrosine phosphatase sigma. Mol. Cell. Biol. 2002, 22:1881-1892.
5. Becker C.M., Sampson D.A., Rupnick M.A., Rohan R.M., Efstathiou J.A., Short S.M., Taylor G.A., Folkman J., D'Amato R.J. Endostatin inhibits the growth of endometriotic lesions but does not affect fertility. Fertil. Steril. 2005, 84(Suppl. 2):1144-1155.
6. Beecken W.D., Engl T., Blaheta R., Bentas W., Achilles E.G., Jonas D., Shing Y., Camphausen K. Angiogenesis inhibition by angiostatin, endostatin and TNP-470 prevents cyclophosphamide induced cystitis. Angiogenesis 2004, 7:69-73.
7. Berger A.C., Feldman A.L., Gnant M.F., Kruger E.A., Sim B.K., Hewitt S., Figg W.D., Alexander H.R., Libutti S.K. The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healing. J. Surg. Res. 2000, 91:26-31.
8. Bishop J.R., Schuksz M., Esko J.D. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 2007, 446:1030-1037.
9. Blanpain C., Lowry W.E., Geoghegan A., Polak L., Fuchs E. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell 2004, 118:635-648.
10. Bloch W., Huggel K., Sasaki T., Grose R., Bugnon P., Addicks K., Timpl R., Werner S. The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing. Faseb J. 2000, 14:2373-2376.
11. Boudko S.P., Sasaki T., Engel J., Lerch T.F., Nix J., Chapman M.S., Bächinger H.P. Crystal structure of human collagen XVIII trimerization domain: A novel collagen trimerization Fold. J. Mol. Biol. 2009, 392:787-802.
12. Brideau G., Mäkinen M.J., Elamaa H., Tu H., Nilsson G., Alitalo K., Pihlajaniemi T., Heljasvaara R. Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice. Cancer Res. 2007, 67:11528-11535.
13. Campbell M., Collery R., McEvoy A., Gardiner T.A., Stitt A.W., Brankin B. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function. Curr. Eye Res. 2006, 31:1033-1045.
14. Carvalhaes L.S., Gervasio O.L., Guatimosim C., Heljasvaara R., Sormunen R., Pihlajaniemi T., Kitten G.T. Collagen XVIII/endostatin is associated with the epithelial-mesenchymal transformation in the atrioventricular valves during cardiac development. Dev. Dyn. 2006, 235:132-142.
15. Castro-Giner F., Bustamante M., Gonzalez J.R., Kogevinas M., Jarvis D., Heinrich J., Anto J.M., Wjst M., Estivill X., de Cid R. A pooling-based genome-wide analysis identifies new potential candidate genes for atopy in the European Community Respiratory Health Survey (ECRHS). BMC Med. Genet. 2009, 10:128.
16. Celie J.W., Keuning E.D., Beelen R.H., Drager A.M., Zweegman S., Kessler F.L., Soininen R., van den Born J. Identification of L-selectin binding heparan sulfates attached to collagen type XVIII. J. Biol. Chem. 2005, 280:26965-26973.
17. Celik I., Surucu O., Dietz C., Heymach J.V., Force J., Hoschele I., Becker C.M., Folkman J., Kisker O. Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve. Cancer Res. 2005, 65:11044-11050.
18. Chang J.H., Javier J.A., Chang G.Y., Oliveira H.B., Azar D.T. Functional characterization of neostatins, the MMP-derived, enzymatic cleavage products of type XVIII collagen. FEBS Lett. 2005, 579:3601-3606.
19. Deininger M.H., Fimmen B., Kremsner P.G., Meyermann R., Schluesener H.J. Accumulation of endostatin/collagenXVIII in brains of patients who died with cerebral malaria. J. Neuroimmunol. 2002, 131:216-221.
20. Deininger M.H., Fimmen B.A., Thal D.R., Schluesener H.J., Meyermann R. Aberrant neuronal and paracellular deposition of endostatin in brains of patients with Alzheimer's disease. J. Neurosci. 2002, 22:10621-10626.
21. Deininger M.H., Meyermann R., Schluesener H.J. Endostatin/collagen XVIII accumulates in patients with traumatic brain injury. J. Neurotrauma 2006, 23:1103-1110.
22. Delaney C.E., Weagant B.T., Addison C.L. The inhibitory effects of endostatin on endothelial cells are modulated by extracellular matrix. Exp. Cell Res. 2006, 312:2476-2489.
23. Dhanabal M., Ramchandran R., Waterman M.J., Lu H., Knebelmann B., Segal M., Sukhatme V.P. Endostatin induces endothelial cell apoptosis. J. Biol. Chem. 1999, 274:11721-11726.
24. Dixelius J., Cross M., Matsumoto T., Sasaki T., Timpl R., Claesson-Welsh L. Endostatin regulates endothelial cell adhesion and cytoskeletal organization. Cancer Res. 2002, 62:1944-1947.
25. Dong S., Cole G.J., Halfter W. Expression of collagen XVIII and localization of its glycosaminoglycan attachment sites. J. Biol. Chem. 2003, 278:1700-1707.
26. Duh E.J., Yao Y.G., Dagli M., Goldberg M.F. Persistence of fetal vasculature in a patient with Knobloch syndrome: potential role for endostatin in fetal vascular remodeling of the eye. Ophthalmology 2004, 111:1885-1888.
27. Eklund L., Piuhola J., Komulainen J., Sormunen R., Ongvarrasopone C., Fássler R., Muona A., Ilves M., Ruskoaho H., Takala T.E., Pihlajaniemi T. Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice. Proc. Natl Acad. Sci. USA 2001, 98:1194-1199.
28. Elamaa H., Peterson J., Pihlajaniemi T., Destree O. Cloning of three variants of type XVIII collagen and their expression patterns during Xenopus laevis development. Mech. Dev. 2002, 114:109-113.
29. Elamaa H., Snellman A., Rehn M., Autio-Harmainen H., Pihlajaniemi T. Characterization of the human type XVIII collagen gene and proteolytic processing and tissue location of the variant containing a frizzled motif. Matrix Biol. 2003, 22:427-442.
30. Elamaa H., Sormunen R., Rehn M., Soininen R., Pihlajaniemi T. Endostatin overexpression specifically in the lens and skin leads to cataract and ultrastructural alterations in basement membranes. Am. J. Pathol. 2005, 166:221-229.
31. Ergun S., Kilic N., Wurmbach J.H., Ebrahimnejad A., Fernando M., Sevinc S., Kilic E., Chalajour F., Fiedler W., Lauke H., Lamszus K., Hammerer P., Weil J., Herbst H., Folkman J. Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes. Angiogenesis 2001, 4:193-206.
32. Errera F.I., Canani L.H., Yeh E., Kague E., Armelin-Correa L.M., Suzuki O.T., Tschiedel B., Silva M.E., Sertie A.L., Passos-Bueno M.R. COL18A1 is highly expressed during human adipocyte differentiation and the SNP c.1136C>T in its "frizzled" motif is associated with obesity in diabetes type 2 patients. An. Acad. Bras. Ciênc. 2008, 80:167-177.
33. Felbor U., Dreier L., Bryant R.A., Ploegh H.L., Olsen B.R., Mothes W. Secreted cathepsin L generates endostatin from collagen XVIII. Embo J. 2000, 19:1187-1194.
34. Feng Y., Wu Y.P., Zhu X.D., Zhang Y.H., Ma Q.J. Endostatin promotes the anabolic program of rabbit chondrocyte. Cell Res. 2005, 15:201-206.
35. Ferreras M., Felbor U., Lenhard T., Olsen B.R., Delaisse J. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett. 2000, 486:247-251.
36. Folkman J. Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action. Exp. Cell Res. 2006, 312:594-607.
37. Fu Y., Tang H., Huang Y., Song N., Luo Y. Unraveling the mysteries of endostatin. IUBMB Life 2009, 61:613-626.
38. Fukai N., Eklund L., Marneros A.G., Oh S.P., Keene D.R., Tamarkin L., Niemelä M., Ilves M., Li E., Pihlajaniemi T., Olsen B.R. Lack of collagen XVIII/endostatin results in eye abnormalities. Embo J. 2002, 21:1535-1544.
39. Hägg P.M., Horelli-Kuitunen N., Eklund L., Palotie A., Pihlajaniemi T. Cloning of mouse type XV collagen sequences and mapping of the corresponding gene to 4B1-3. Comparison of mouse and human alpha 1 (XV) collagen sequences indicates divergence in the number of small collagenous domains. Genomics 1997, 45:31-41.
40. Halfter W., Dong S., Schurer B., Cole G.J. Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J. Biol. Chem. 1998, 273:25404-25412.
41. Hamano Y., Okude T., Shirai R., Sato I., Kimura R., Ogawa M., Ueda Y., Yokosuka O., Kalluri R., Ueda S. Lack of Collagen XVIII/Endostatin Exacerbates Immune-Mediated Glomerulonephritis. J. Am. Soc. Nephrol. 2010, 21:1445-1455.
42. Hanai J., Dhanabal M., Karumanchi S.A., Albanese C., Waterman M., Chan B., Ramchandran R., Pestell R., Sukhatme V.P. Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1. J. Biol. Chem. 2002, 277:16464-16469.
43. Hanai J., Gloy J., Karumanchi S.A., Kale S., Tang J., Hu G., Chan B., Ramchandran R., Jha V., Sukhatme V.P., Sokol S. Endostatin is a potential inhibitor of Wnt signaling. J. Cell Biol. 2002, 158:529-539.
44. Hasle H., Clemmensen I.H., Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 2000, 355:165-169.
45. Heljasvaara R., Nyberg P., Luostarinen J., Parikka M., Heikkilä P., Rehn M., Sorsa T., Salo T., Pihlajaniemi T. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases. Exp. Cell Res. 2005, 307:292-304.
46. Hu T.H., Huang C.C., Wu C.L., Lin P.R., Liu S.Y., Lin J.W., Chuang J.H., Tai M.H. Increased endostatin/collagen XVIII expression correlates with elevated VEGF level and poor prognosis in hepatocellular carcinoma. Mod. Pathol. 2005, 18:663-672.
47. Hurskainen M., Eklund L., Hägg P.O., Fruttiger M., Sormunen R., Ilves M., Pihlajaniemi T. Abnormal maturation of the retinal vasculature in type XVIII collagen/endostatin deficient mice and changes in retinal glial cells due to lack of collagen types XV and XVIII. Faseb J. 2005, 19:1564-1566.
48. Ichinose K., Maeshima Y., Yamamoto Y., Kitayama H., Takazawa Y., Hirokoshi K., Sugiyama H., Yamasaki Y., Eguchi K., Makino H. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model. Diabetes 2005, 54:2891-2903.
49. Inoue-Murayama M., Sugimoto Y., Niimi Y., Aso H. Type XVIII collagen is newly transcribed during bovine adipogenesis. Differentiation 2000, 65:281-285.
50. Iozzo R.V., Zoeller J.J., Nystrom A. Basement membrane proteoglycans: modulators Par Excellence of cancer growth and angiogenesis. Mol. Cells 2009, 27:503-513.
51. Isobe K., Kuba K., Maejima Y., Suzuki J., Kubota S., Isobe M. Inhibition of endostatin/collagen XVIII deteriorates left ventricular remodeling and heart failure in rat myocardial infarction model. Circ. J. 2010, 74:109-119.
52. Javaherian K., Park S.Y., Pickl W.F., LaMontagne K.R., Sjin R.T., Gillies S., Lo K.M. Laminin modulates morphogenic properties of the collagen XVIII endostatin domain. J. Biol. Chem. 2002, 277:45211-45218.
53. Karamouzis M.V., Moschos S.J. The use of endostatin in the treatment of solid tumors. Expert Opin. Biol. Ther. 2009, 9:641-648.
54. Karumanchi S.A., Jha V., Ramchandran R., Karihaloo A., Tsiokas L., Chan B., Dhanabal M., Hanai J.I., Venkataraman G., Shriver Z., Keiser N., Kalluri R., Zeng H., Mukhopadhyay D., Chen R.L., Lander A.D., Hagihara K., Yamaguchi Y., Sasisekharan R., Cantley L., Sukhatme V.P. Cell surface glypicans are low-affinity endostatin receptors. Mol. Cell 2001, 7:811-822.
55. Kawashima H., Watanabe N., Hirose M., Sun X., Atarashi K., Kimura T., Shikata K., Matsuda M., Ogawa D., Heljasvaara R., Rehn M., Pihlajaniemi T., Miyasaka M. Collagen XVIII, a basement membrane heparan sulfate proteoglycan, interacts with L-selectin and monocyte chemoattractant protein-1. J. Biol. Chem. 2003, 278:13069-13076.
56. Keren B., Suzuki O.T., Gerard-Blanluet M., Bremond-Gignac D., Elmaleh M., Titomanlio L., Delezoide A.L., Passos-Bueno M.R., Verloes A. CNS malformations in Knobloch syndrome with splice mutation in COL18A1 gene. Am. J. Med. Genet. A 2007, 143A:1514-1518.
57. Khan Z.A., Melero-Martin J.M., Wu X., Paruchuri S., Boscolo E., Mulliken J.B., Bischoff J. Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. Blood 2006, 108:915-921.
58. Kim Y.M., Jang J.W., Lee O.H., Yeon J., Choi E.Y., Kim K.W., Lee S.T., Kwon Y.G. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase. Cancer Res. 2000, 60:5410-5413.
59. Kim Y.M., Hwang S., Kim Y.M., Pyun B.J., Kim T.Y., Lee S.T., Gho Y.S., Kwon Y.G. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J. Biol. Chem. 2002, 277:27872-27879.
60. Kivirikko S., Heinämäki P., Rehn M., Honkanen N., Myers J.C., Pihlajaniemi T. Primary structure of the alpha 1 chain of human type XV collagen and exon-intron organization in the 3' region of the corresponding gene. J. Biol. Chem. 1994, 269:4773-4779.
61. Kliemann S.E., Waetge R.T., Suzuki O.T., Passos-Bueno M.R., Rosemberg S. Evidence of neuronal migration disorders in Knobloch syndrome: clinical and molecular analysis of two novel families. Am. J. Med. Genet. A 2003, 119A:15-19.
62. Kojima T., Azar D.T., Chang J.H. Neostatin-7 regulates bFGF-induced corneal lymphangiogenesis. FEBS Lett. 2008, 582:2515-2520.
63. Kulke M.H., Bergsland E.K., Ryan D.P., Enzinger P.C., Lynch T.J., Zhu A.X., Meyerhardt J.A., Heymach J.V., Fogler W.E., Sidor C., Michelini A., Kinsella K., Venook A.P., Fuchs C.S. Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors. J. Clin. Oncol. 2006, 24:3555-3561.
64. Kuo C.J., LaMontagne K.R., Garcia-Cardena G., Ackley B.D., Kalman D., Park S., Christofferson R., Kamihara J., Ding Y.H., Lo K.M., Gillies S., Folkman J., Mulligan R.C., Javaherian K. Oligomerization-dependent regulation of motility and morphogenesis by the collagen XVIII NC1/endostatin domain. J. Cell Biol. 2001, 152:1233-1246.
65. Lau K.H., Kapur S., Kesavan C., Baylink D.J. Up-regulation of the Wnt, estrogen receptor, insulin-like growth factor-I, and bone morphogenetic protein pathways in C57BL/6J osteoblasts as opposed to C3H/HeJ osteoblasts in part contributes to the differential anabolic response to fluid shear. J. Biol. Chem. 2006, 281:9576-9588.
66. Li Q., Olsen B.R. Increased angiogenic response in aortic explants of collagen XVIII/endostatin-null mice. Am. J. Pathol. 2004, 165:415-424.
67. Li D., Clark C.C., Myers J.C. Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells. J. Biol. Chem. 2000, 275:22339-22347.
68. Lietard J., Theret N., Rehn M., Musso O., Dargere D., Pihlajaniemi T., Clement B. The promoter of the long variant of collagen XVIII, the precursor of endostatin, contains liver-specific regulatory elements. Hepatology 2000, 32:1377-1385.
69. Lin Y., Zhang S., Rehn M., Itäranta P., Tuukkanen J., Heljasvaara R., Peltoketo H., Pihlajaniemi T., Vainio S. Induced repatterning of type XVIII collagen expression in ureter bud from kidney to lung type: association with sonic hedgehog and ectopic surfactant protein C. Development 2001, 128:1573-1585.
70. Ma L., Elliott S.N., Cirino G., Buret A., Ignarro L.J., Wallace J.L. Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release. Proc. Natl Acad. Sci. USA 2001, 98:6470-6475.
71. Määttä M., Heljasvaara R., Pihlajaniemi T., Uusitalo M. Collagen XVIII/endostatin shows a ubiquitous distribution in human ocular tissues and endostatin-containing fragments accumulate in ocular fluid samples. Graefes Arch. Clin. Exp. Ophthalmol. 2007, 245:74-81.
72. Marneros A.G., Olsen B.R. Age-dependent iris abnormalities in collagen XVIII/endostatin deficient mice with similarities to human pigment dispersion syndrome. Invest. Ophthalmol. Vis. Sci. 2003, 44:2367-2372.
73. Marneros A.G., Keene D.R., Hansen U., Fukai N., Moulton K., Goletz P.L., Moiseyev G., Pawlyk B.S., Halfter W., Dong S., Shibata M., Li T., Crouch R.K., Bruckner P., Olsen B.R. Collagen XVIII/endostatin is essential for vision and retinal pigment epithelial function. Embo J. 2004, 23:89-99.
74. Matsuno H., Yudoh K., Uzuki M., Nakazawa F., Sawai T., Yamaguchi N., Olsen B.R., Kimura T. Treatment with the angiogenesis inhibitor endostatin: a novel therapy in rheumatoid arthritis. J. Rheumatol. 2002, 29:890-895.
75. Michaels J.5., Dobryansky M., Galiano R.D., Bhatt K.A., Ashinoff R., Ceradini D.J., Gurtner G.C. Topical vascular endothelial growth factor reverses delayed wound healing secondary to angiogenesis inhibitor administration. Wound Repair Regen. 2005, 13:506-512.
76. Miled C., Pontoglio M., Garbay S., Yaniv M., Weitzman J.B. A genomic map of p53 binding sites identifies novel p53 targets involved in an apoptotic network. Cancer Res. 2005, 65:5096-5104.
77. Miosge N., Sasaki T., Timpl R. Angiogenesis inhibitor endostatin is a distinct component of elastic fibers in vessel walls. Faseb J. 1999, 13:1743-1750.
78. Miosge N., Simniok T., Sprysch P., Herken R. The collagen type XVIII endostatin domain is co-localized with perlecan in basement membranes in vivo. J. Histochem. Cytochem. 2003, 51:285-296.
79. Mori K., Ando A., Gehlbach P., Nesbitt D., Takahashi K., Goldsteen D., Penn M., Chen C.T., Mori K., Melia M., Phipps S., Moffat D., Brazzell K., Liau G., Dixon K.H., Campochiaro P.A. Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin. Am. J. Pathol. 2001, 159:313-320.
80. Moschos S.J., Odoux C., Land S.R., Agarwala S., Friedland D., Volker K.M., Sidor C., Wong M., Kirkwood J.M. Endostatin plus interferon-alpha2b therapy for metastatic melanoma: a novel combination of antiangiogenic and immunomodulatory agents. Melanoma Res. 2007, 17:193-200.
81. Moulton K.S., Heller E., Konerding M.A., Flynn E., Palinski W., Folkman J. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 1999, 99:1726-1732.
82. Moulton K.S., Olsen B.R., Sonn S., Fukai N., Zurakowski D., Zeng X. Loss of collagen XVIII enhances neovascularization and vascular permeability in atherosclerosis. Circulation 2004, 110:1330-1336.
83. Mueller C.A., Schluesener H.J., Fauser U., Conrad S., Schwab J.M. Lesional expression of the endogenous angiogenesis inhibitor endostatin/collagen XVIII following traumatic brain injury (TBI). Exp. Neurol. 2007, 208:228-237.
84. Muragaki Y., Abe N., Ninomiya Y., Olsen B.R., Ooshima A. The human alpha 1(XV) collagen chain contains a large amino-terminal non-triple helical domain with a tandem repeat structure and homology to alpha 1(XVIII) collagen. J. Biol. Chem. 1994, 269:4042-4046.
85. Muragaki Y., Timmons S., Griffith C.M., Oh S.P., Fadel B., Quertermous T., Olsen B.R. Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones. Proc. Natl Acad. Sci. USA 1995, 92:8763-8767.
86. Musso O., Rehn M., Saarela J., Theret N., Lietard J., Hintikka, Lotrian D., Campion J.P., Pihlajaniemi T., Clement B. Collagen XVIII is localized in sinusoids and basement membrane zones and expressed by hepatocytes and activated stellate cells in fibrotic human liver. Hepatology 1998, 28:98-107.
87. Musso O., Theret N., Heljasvaara R., Rehn M., Turlin B., Campion J.P., Pihlajaniemi T., Clement B. Tumor hepatocytes and basement membrane-Producing cells specifically express two different forms of the endostatin precursor, collagen XVIII, in human liver cancers. Hepatology 2001, 33:868-876.
88. Musso O., Rehn M., Théret N., Turlin B., Bioulac-Sage P., Lotrian D., Campion J.P., Pihlajaniemi T., Clément B. Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen XVIII in human hepatocellular carcinomas. Cancer Res. 2001, 61:45-49.
89. Nasu K., Nishida M., Fukuda J., Kawano Y., Nishida Y., Miyakawa I. Hypoxia simultaneously inhibits endostatin production and stimulates vascular endothelial growth factor production by cultured human endometrial stromal cells. Fertil. Steril. 2004, 82:756-759.
90. Nicolae C., Olsen B.R. Unexpected matrix diseases and novel therapeutic strategies. Cell Tissue Res. 2010, 339:155-165.
91. Nyberg P., Heikkilä P., Sorsa T., Luostarinen J., Heljasvaara R., Stenman U.H., Pihlajaniemi T., Salo T. Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13. J. Biol. Chem. 2003, 278:22404-22411.
92. Oh S.P., Kamagata Y., Muragaki Y., Timmons S., Ooshima A., Olsen B.R. Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins. Proc. Natl Acad. Sci. USA 1994, 91:4229-4233.
93. Oh S.P., Warman M.L., Seldin M.F., Cheng S.D., Knoll J.H., Timmons S., Olsen B.R. Cloning of cDNA and genomic DNA encoding human type XVIII collagen and localization of the alpha 1(XVIII) collagen gene to mouse chromosome 10 and human chromosome 21. Genomics 1994, 19:494-499.
94. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R., Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88:277-285.
95. Passos-Bueno M.R., Suzuki O.T., Armelin-Correa L.M., Sertie A.L., Errera F.I., Bagatini K., Kok F., Leite K.R. Mutations in collagen 18A1 and their relevance to the human phenotype. An. Acad. Bras. Ciênc. 2006, 78:123-131.
96. Peeters C.F., de Geus L.F., Westphal J.R., de Waal R.M., Ruiter D.J., Wobbes T., Oyen W.J., Ruers T.J. Decrease in circulating anti-angiogenic factors (angiostatin and endostatin) after surgical removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases. Surgery 2005, 137:246-249.
97. Pollheimer J., Husslein P., Knofler M. Invasive trophoblasts generate regulatory collagen XVIII cleavage products. Placenta 2005, 26(Suppl. A):S42-S45.
98. Pufe T., Petersen W.J., Miosge N., Goldring M.B., Mentlein R., Varoga D.J., Tillmann B.N. Endostatin/collagen XVIII-an inhibitor of angiogenesis-is expressed in cartilage and fibrocartilage. Matrix Biol. 2004, 23:267-276.
99. Quelard D., Lavergne E., Hendaoui I., Elamaa H., Tiirola U., Heljasvaara R., Pihlajaniemi T., Clement B., Musso O. A cryptic frizzled module in cell surface collagen 18 inhibits Wnt/beta-catenin signaling. PLoS ONE 2008, 3:e1878.
100. Ramchandran R., Dhanabal M., Volk R., Waterman M.J., Segal M., Lu H., Knebelmann B., Sukhatme V.P. Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Biochem. Biophys. Res. Commun. 1999, 255:735-739.
101. Rasi K., Piuhola J., Czabanka M., Sormunen R., Ilves M., Leskinen H., Rysä J., Kerkelä R., Janmey P., Heljasvaara R., Peuhkurinen K., Vuolteenaho O., Ruskoaho H., Vajkoczy P., Pihlajaniemi T., Eklund L. Collagen XV Is Necessary for Modeling of the Extracellular Matrix and Its Deficiency Predisposes to Cardiomyopathy. Circ. Res. 2010, 107:1241-1252.
102. Rastinejad F., Polverini P.J., Bouck N.P. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 1989, 56:345-355.
103. Rehn M., Pihlajaniemi T. Alpha 1(XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen. Proc. Natl Acad. Sci. USA 1994, 91:4234-4238.
104. Rehn M., Pihlajaniemi T. Identification of three N-terminal ends of type XVIII collagen chains and tissue-specific differences in the expression of the corresponding transcripts. The longest form contains a novel motif homologous to rat and Drosophila frizzled proteins. J. Biol. Chem. 1995, 270:4705-4711.
105. Rehn M., Hintikka E., Pihlajaniemi T. Primary structure of the alpha 1 chain of mouse type XVIII collagen, partial structure of the corresponding gene, and comparison of the alpha 1(XVIII) chain with its homologue, the alpha 1(XV) collagen chain. J. Biol. Chem. 1994, 269:13929-13935.
106. Rehn M., Hintikka E., Pihlajaniemi T. Characterization of the mouse gene for the alpha 1 chain of type XVIII collagen (Col18a1) reveals that the three variant N-terminal polypeptide forms are transcribed from two widely separated promoters. Genomics 1996, 32:436-446.
107. Rehn M., Veikkola T., Kukk-Valdre E., Nakamura H., Ilmonen M., Lombardo C., Pihlajaniemi T., Alitalo K., Vuori K. Interaction of endostatin with integrins implicated in angiogenesis. Proc. Natl Acad. Sci. USA 2001, 98:1024-1029.
108. Richter A.G., McKeown S., Rathinam S., Harper L., Rajesh P., McAuley D.F., Heljasvaara R., Thickett D.R. Soluble endostatin is a novel inhibitor of epithelial repair in idiopathic pulmonary fibrosis. Thorax 2009, 64:156-161.
109. Rossi M., Morita H., Sormunen R., Airenne S., Kreivi M., Wang L., Fukai N., Olsen B.R., Tryggvason K., Soininen R. Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney. Embo J. 2003, 22:236-245.
110. Saarela J., Rehn M., Oikarinen A., Autio-Harmainen H., Pihlajaniemi T. The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans. Am. J. Pathol. 1998, 153:611-626.
111. Saarela J., Ylikarppa R., Rehn M., Purmonen S., Pihlajaniemi T. Complete primary structure of two variant forms of human type XVIII collagen and tissue-specific differences in the expression of the corresponding transcripts. Matrix Biol. 1998, 16:319-328.
112. Santos S.N., Oliveira G.V., Tavares A.L., Massensini A.R., Carvalhaes L.M., Reljasvaara R., Kitten G.T. Collagen XVIII and fibronectin involvement in bullous scleroderma. Dermatol. Online J. 2005, 11:17.
113. Sasaki T., Fukai N., Mann K., Gohring W., Olsen B.R., Timpl R. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. Embo J. 1998, 17:4249-4256.
114. Sasaki T., Larsson H., Tisi D., Claesson-Welsh L., Hohenester E., Timpl R. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity. J. Mol. Biol. 2000, 301:1179-1190.
115. Schmidt A., Addicks K., Bloch W. Opposite effects of endostatin on different endothelial cells. Cancer Biol. Ther. 2004, 3:1162-1166. discussion 1167-8.
116. Schmidt A., Wenzel D., Thorey I., Sasaki T., Hescheler J., Timpl R., Addicks K., Werner S., Fleischmann B.K., Bloch W. Endostatin influences endothelial morphology via the activated ERK1/2-kinase endothelial morphology and signal transduction. Microvasc. Res. 2006, 71:152-162.
117. Schneider V.A., Granato M. The myotomal diwanka (lh3) glycosyltransferase and type XVIII collagen are critical for motor growth cone migration. Neuron 2006, 50:683-695.
118. Schuch G., Heymach J.V., Nomi M., Machluf M., Force J., Atala A., Eder J.P., Folkman J., Soker S. Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells. Cancer Res. 2003, 63:8345-8350.
119. Seppinen L., Sormunen R., Soini Y., Elamaa H., Heljasvaara R., Pihlajaniemi T. Lack of collagen XVIII accelerates cutaneous wound healing, while overexpression of its endostatin domain leads to delayed healing. Matrix Biol. 2008, 27:535-546.
120. Sertie A.L., Sossi V., Camargo A.A., Zatz M., Brahe C., Passos-Bueno M.R. Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome). Hum. Mol. Genet. 2000, 9:2051-2058.
121. Shao X.J., Xie F.M. Influence of angiogenesis inhibitors, endostatin and PF-4, on lymphangiogenesis. Lymphology 2005, 38:1-8.
122. Shichiri M., Hirata Y. Antiangiogenesis signals by endostatin. Faseb J. 2001, 15:1044-1053.
123. Sipola A., Nelo K., Hautala T., Ilvesaro J., Tuukkanen J. Endostatin inhibits VEGF-A induced osteoclastic bone resorption in vitro. BMC Musculoskelet. Disord. 2006, 7:56.
124. Sipola A., Ilvesaro J., Birr E., Jalovaara P., Pettersson R.F., Stenback F., Ylä-Herttuala S., Hautala T., Tuukkanen J. Endostatin inhibits endochondral ossification. J. Gene Med. 2007, 9:1057-1064.
125. Sipola A., Seppinen L., Pihlajaniemi T., Tuukkanen J. Endostatin Affects Osteoblast Behavior In Vitro, but Collagen XVIII/Endostatin Is Not Essential for Skeletal Development In Vivo. Calcif. Tissue Int. 2010, 85:412-420.
126. Skovseth D.K., Veuger M.J., Sorensen D.R., De Angelis P.M., Haraldsen G. Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo. Blood 2005, 105:1044-1051.
127. Sudhakar A., Sugimoto H., Yang C., Lively J., Zeisberg M., Kalluri R. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc. Natl Acad. Sci. USA 2003, 100:4766-4771.
128. Sun X., Qiao H., Jiang H., Zhi X., Liu F., Wang J., Liu M., Dong D., Kanwar J.R., Xu R., Krissansen G.W. Intramuscular delivery of antiangiogenic genes suppresses secondary metastases after removal of primary tumors. Cancer Gene Ther. 2005, 12:35-45.
129. Sund M., Kalluri R. Tumor stroma derived biomarkers in cancer. Cancer Metastasis Rev. 2009, 28:177-183.
130. Sund M., Hamano Y., Sugimoto H., Sudhakar A., Soubasakos M., Yerramalla U., Benjamin L.E., Lawler J., Kieran M., Shah A., Kalluri R. Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors. Proc. Natl Acad. Sci. USA 2005, 102:2934-2939.
131. Suzaki Y., Hamada K., Sho M., Ito T., Miyamoto K., Akashi S., Kashizuka H., Ikeda N., Nakajima Y., Iwase M., Homma I., Kobzik L., Kimura H. A potent antiangiogenic factor, endostatin prevents the development of asthma in a murine model. J. Allergy Clin. Immunol. 2005, 116:1220-1227.
132. Suzuki O.T., Sertie A.L., Der Kaloustian V.M., Kok F., Carpenter M., Murray J., Czeizel A.E., Kliemann S.E., Rosemberg S., Monteiro M., Olsen B.R., Passos-Bueno M.R. Molecular analysis of collagen XVIII reveals novel mutations, presence of a third isoform, and possible genetic heterogeneity in Knobloch syndrome. Am. J. Hum. Genet. 2002, 71:1320-1329.
133. Suzuki O., Kague E., Bagatini K., Tu H., Heljasvaara R., Carvalhaes L., Gava E., de Oliveira G., Godoi P., Oliva G., Kitten G., Pihlajaniemi T., Passos-Bueno M.R. Novel pathogenic mutations and skin biopsy analysis in Knobloch syndrome. Mol. Vis. 2009, 15:801-809.
134. Takahashi K., Saishin Y., Saishin Y., Silva R.L., Oshima Y., Oshima S., Melia M., Paszkiet B., Zerby D., Kadan M.J., Liau G., Kaleko M., Connelly S., Luo T., Campochiaro P.A. Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment. Faseb J. 2003, 17:896-898.
135. Tanabe K., Maeshima Y., Ichinose K., Kitayama H., Takazawa Y., Hirokoshi K., Kinomura M., Sugiyama H., Makino H. Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model. Kidney Int. 2007, 71:227-238.
136. Teodoro J.G., Parker A.E., Zhu X., Green M.R. P53-Mediated Inhibition of Angiogenesis through Up-Regulation of a Collagen Prolyl Hydroxylase. Science 2006, 313:968-971.
137. Tjin Tham Sjin R.M., Naspinski J., Birsner A.E., Li C., Chan R., Lo K.M., Gillies S., Zurakowski D., Folkman J., Samulski J., Javaherian K. Endostatin therapy reveals a U-shaped curve for antitumor activity. Cancer Gene Ther. 2006, 13:619-627.
138. Tumbar T., Guasch G., Greco V., Blanpain C., Lowry W.E., Rendl M., Fuchs E. Defining the epithelial stem cell niche in skin. Science 2004, 303:359-363.
139. Utriainen A., Sormunen R., Kettunen M., Carvalhaes L.S., Sajanti E., Eklund L., Kauppinen R., Kitten G.T., Pihlajaniemi T. Structurally altered basement membranes and hydrocephalus in a type XVIII collagen deficient mouse line. Hum. Mol. Genet. 2004, 13:2089-2099.
140. Vaananen A., Tjaderhane L., Eklund L., Heljasvaara R., Pihlajaniemi T., Herva R., Ding Y., Bartlett J.D., Salo T. Expression of collagen XVIII and MMP-20 in developing teeth and odontogenic tumors. Matrix Biol. 2004, 23:153-161.
141. van Horssen J., Wilhelmus M.M., Heljasvaara R., Pihlajaniemi T., Wesseling P., de Waal R.M., Verbeek M.M. Collagen XVIII: a novel heparan sulfate proteoglycan associated with vascular amyloid depositions and senile plaques in Alzheimer's disease brains. Brain Pathol. 2002, 12:456-462.
142. Wen W., Moses M.A., Wiederschain D., Arbiser J.L., Folkman J. The generation of endostatin is mediated by elastase. Cancer Res. 1999, 59:6052-6056.
143. Wickström S.A., Veikkola T., Rehn M., Pihlajaniemi T., Alitalo K., Keski-Oja J. Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells. Cancer Res. 2001, 61:6511-6516.
144. Wickström S.A., Alitalo K., Keski-Oja J. Endostatin associates with integrin alpha5beta1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells. Cancer Res. 2002, 62:5580-5589.
145. Wickström S.A., Alitalo K., Keski-Oja J. Endostatin associates with lipid rafts and induces reorganization of the actin cytoskeleton via down-regulation of RhoA activity. J. Biol. Chem. 2003, 278:37895-37901.
146. Wilson R.F., Morse M.A., Pei P., Renner R.J., Schuller D.E., Robertson F.M., Mallery S.R. Endostatin inhibits migration and invasion of head and neck squamous cell carcinoma cells. Anticancer Res. 2003, 23:1289-1295.
147. Wu P., Yonekura H., Li H., Nozaki I., Tomono Y., Naito I., Ninomiya Y., Yamamoto H. Hypoxia down-regulates endostatin production by human microvascular endothelial cells and pericytes. Biochem. Biophys. Res. Commun. 2001, 288:1149-1154.
148. Wu F.P., Westphal J.R., Hoekman K., Mels A.K., Statius Muller M.G., de Waal R.W., Beelen R.H., van Leeuwen P.A., Meijer S., Cuesta M.A. The effects of surgery, with or without rhGM-CSF, on the angiogenic profile of patients treated for colorectal carcinoma. Cytokine 2004, 25:68-72.
149. Yamaguchi N., Anand-Apte B., Lee M., Sasaki T., Fukai N., Shapiro R., Que I., Lowik C., Timpl R., Olsen B.R. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. Embo J. 1999, 18:4414-4423.
150. Yin G., Liu W., An P., Li P., Ding I., Planelles V., Schwarz E.M., Min W. Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis. Mol. Ther. 2002, 5:547-554.
151. Ylikärppä R., Eklund L., Sormunen R., Kontiola A.I., Utriainen A., Maatta M., Fukai N., Olsen B.R., Pihlajaniemi T. Lack of type XVIII collagen results in anterior ocular defects. Faseb J. 2003, 17:2257-2259.
152. Ylikärppä R., Eklund L., Sormunen R., Muona A., Fukai N., Olsen B.R., Pihlajaniemi T. Double knockout mice reveal a lack of major functional compensation between collagens XV and XVIII. Matrix Biol. 2003, 22:443-448.
153. Zeng X., Chen J., Miller Y.I., Javaherian K., Moulton K.S. Endostatin binds biglycan and LDL and interferes with LDL retention to the subendothelial matrix during atherosclerosis. J. Lipid Res. 2005, 46:1849-1859.
154. Zorick T.S., Mustacchi Z., Bando S.Y., Zatz M., Moreira-Filho C.A., Olsen B., Passos-Bueno M.R. High serum endostatin levels in Down syndrome: implications for improved treatment and prevention of solid tumours. Eur. J. Hum. Genet. 2001, 9:811-814.